|
MAX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.773200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.459000E-01 |
| Normal-vs-Stage2 |
9.194000E-01 |
| Normal-vs-Stage3 |
9.159800E-01 |
| Normal-vs-Stage4 |
6.986600E-01 |
| Stage1-vs-Stage2 |
6.356000E-01 |
| Stage1-vs-Stage3 |
4.773800E-01 |
| Stage1-vs-Stage4 |
8.067400E-01 |
| Stage2-vs-Stage3 |
9.758400E-01 |
| Stage2-vs-Stage4 |
8.412800E-01 |
| Stage3-vs-Stage4 |
7.717800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.286400E-01 |
| Normal-vs-AfricanAmerican |
5.047800E-01 |
| Normal-vs-Asian |
3.230500E-02 |
| Caucasian-vs-AfricanAmerican |
7.629000E-01 |
| Caucasian-vs-Asian |
1.352560E-01 |
| AfricanAmerican-vs-Asian |
4.365200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.119200E-01 |
| Normal-vs-Female |
2.546000E-01 |
| Male-vs-Female |
1.100350E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.941600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.732800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.176000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.402290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.548600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.414580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.246000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.971900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.839150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.554200E-01 |
| Classical-VS-Follicular |
4.387900E-02 |
| Classical-VS-Other |
7.232200E-01 |
| Classical-VS-Normal |
1.423640E-01 |
| Tall-VS-Follicular |
5.422400E-01 |
| Tall-VS-Other |
9.789400E-01 |
| Tall-VS-Normal |
9.538600E-01 |
| Follicular-VS-Other |
7.723400E-01 |
| Follicular-VS-Normal |
4.774400E-01 |
| Other-VS-Normal |
9.646600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.751600E-01 |
| Normal-vs-N1 |
5.017800E-01 |
| N0-vs-N1 |
1.745640E-01 |
|
|
